All articles by Vidya Sagar Maddela
Vidya Sagar Maddela
MedAxiom Announces Industry Partnership With Zywie
Zywie offers multiple types of monitors to fit the needs of every physician and patient, including the ZywieNano patch
Orlando Health to buy Tenet’s majority stake in Brookwood Baptist Health
Established in 2015, through a merger agreement between Tenet Healthcare and Baptist Health System, Brookwood Baptist Health comprises five hospitals with more than 1,700 beds, and 70 primary and speciality care clinics
CUSM Receives Grant From Bank of America to Support Access to Healthcare in Rural Inland Empire Communities
California University of Science and Medicine (CUSM) is dedicated to advancing the art and science of medicine through medical education, research, and compassionate healthcare delivery in an inclusive environment
The Department of Health – Abu Dhabi provides gene therapy for Duchenne Muscular Dystrophy for the first time in Abu Dhabi and outside the US
DMD is a hereditary neuromuscular disorder that causes the muscles to gradually weaken over time
Anivive secures NIAID funding to advance Valley Fever vaccine
The NIH funding aims to use the science behind Anivive’s animal health Valley Fever vaccine for dogs, which is currently being reviewed by the USDA Center for Veterinary Biologics, to develop a similar vaccine for humans
VSee Health partners with Ava Robotics to develop telepresence robot for ICUs
Under the collaboration, Ava Robot will develop a robot, powered by VSee software, to expand the reach of telehealth solutions beyond large hospitals, making it accessible to regional hospitals and smaller ICUs
AmeriPro Health Expands Services in Michigan with Acquisition of Rapid Response EMS
AmeriPro Health will provide ambulance services in Detroit, Southgate, Highland Park, Hamtramck, and River Rouge.
GE HealthCare reports 2% rise in Q2 2024 net income to $428m
The US-based health technology company reported a total revenue of $4.83bn for Q2 2024, a 0.5% rise compared to $4.81bn for the same quarter in 2023, and a 4% increase compared to $4.65bn for Q1 2024
HARTING AG – The Future of Wearable Tech: Smaller, Smarter, and More Comfortable with 3D-Circuits
HARTING is a global leader in the field of electrical and electronic connectors, device terminations, and network components, as well as ready-to-use systems
Biogen, Beckman Coulter and Fujirebio partner to develop biomarker tests for AD
The collaboration aims to identify and develop accessible, minimally invasive blood-based biomarkers specific for tau pathology in the brain, with plans to clinically advance and commercialise new tests for Alzheimer’s disease